YOU ARE HERE: LAT HomeCollectionsNasal Spray

Nasal Spray

July 11, 1988 | DR. NEIL SOLOMON
Question: Is there any possibility that the insulin nasal spray for diabetics will ever replace insulin injections? Doctors complain that patients don't follow their instructions, but I'd be willing to bet that patients would use the nasal spray more conscientiously. I would also like to know if the insulin in the spray is the same as that used for injections. Answer: The results of various studies indicate that the insulin nasal spray can be as effective as insulin injections.
August 20, 2010 | By Thomas H. Maugh II, Los Angeles Times
Dr. Robert M. Chanock, a virologist who made a remarkable series of discoveries about respiratory viruses in the 1960s and 1970s, including the isolation of the deadly respiratory syncytial virus and four para- influenza viruses, died Aug. 4 at a residential care center in Sykesville, Md. He was 86 and had Alzheimer's disease. Chanock also identified the cause of what was once called walking pneumonia, developed an adenovirus vaccine that is widely used by the military, laid the foundation for the discovery of hepatitis A and C and the development of vaccines against them, pioneered the development of the nasal spray influenza vaccine and played a key role in the discovery of the Norwalk virus, the first member of the family of viruses that cause what is generally known as intestinal flu. One of his biggest disappointments was his team's inability to develop a vaccine against the respiratory syncytial virus, but they did develop antibodies that could be used to protect infants at high risk for the disease.
November 17, 1985 | Associated Press
Troublesome, sometimes painful injections of insulin that diabetics endure each day might be a thing of the past if tests on an insulin nasal spray are successful, a company said Monday. The federal Food and Drug Administration gave California Biotechnology Inc. permission on Friday to start testing the nose spray on patients. "Every diabetic has to inject himself one to three times a day," David Lauck, director of regulatory affairs and clinical research for the company.
December 21, 2009 | By Emily Sohn
With at least two flus and plenty of colds, coughs and sore throats circulating this season, some Americans are turning to zinc to ward off viruses. Lozenges, supplements and nasal sprays that contain the mineral claim to boost immunity, and there is some evidence that they might do so. In an effort to stay well, though, we might be making ourselves sick. Consistently taking excessive FOR THE RECORD: Dietitian's name: An earlier version of this article misspelled the name of dietitian Ruth Frechman as Frenchman.
August 25, 1995 | Times Wire Services
The Food and Drug Administration has approved an easier way for some women with osteoporosis to take their medicine. The best treatment is the hormone estrogen, but many women suffer side effects, including a possibly higher risk of certain cancers. For those women, the only alternative has been injections of the hormone calcitonin, which is derived from salmon. The FDA recently approved a version of calcitonin in an easier-to-use nasal spray, called Miacalcin.
August 30, 1997 | From Reuters
The U.S. Food and Drug Administration has approved a new nasal spray for treating migraines, maker Glaxo Wellcome said Friday. London-based Glaxo said it would start marketing the spray version of Imitrex in October. Imitrex, also known as Imigran, is the first of a new class of drugs known as triptans. Imigran chalked up sales of $500 million in the first half of 1996. Imitrex is estimated to hold more than 70% of the $1.
May 27, 1986 | ALLAN PARACHINI, Times Staff Writer
The long, frustrating search for a drug treatment to substitute for surgery in most cases of endometriosis--a disease that may affect as many as 15% of all pre-menopausal American women--may be nearing a decisive end, doctors at UCLA and in San Francisco agree.
The alleged weapon was a bottle of nasal spray laced with poison. The man charged with attempted murder hardly has the look of a killer. John Linner's beefy body is usually framed by sandals and baseball caps, and he prides himself on his chili-fixing ability. He is also a research scientist who developed a breakthrough process in the world of cryobiology, the study of organisms at reduced temperatures. And now he sits in the Montgomery County jail in Conroe, Tex.
June 7, 2005 | Myron Levin, Times Staff Writer
Drug maker Wyeth removed a mercury compound from a popular nasal spray more than a decade ago to skirt warning label requirements, but continued using the chemical in infant vaccines for several years until it came under pressure to stop.
A cold is like a divorce, or the decline of the Roman Empire, or trying on dresses and discovering you're a size 14 now, or waking up hung over with a tattoo and a girl, neither of which you recognize: No one can say when it starts.
October 14, 2009 | Molly Hennessy-Fiske
Los Angeles County residents without health insurance or a personal doctor will be eligible for free H1N1 flu vaccines at county-sponsored clinics starting next Friday. The county's first shipment of H1N1 nasal spray vaccines arrived last week, and public health officials said they expect to receive further supplies every two weeks until at least December. The federal government is buying and distributing the vaccines to states in proportion to their populations. The county-sponsored clinics will be held at area parks, churches, schools and community centers, and will offer both H1N1 FluMist nasal spray and vaccines (including preservative-free versions)
October 5, 2009 | Molly Hennessy-Fiske
Los Angeles public health officials say they expect to receive the first shipments of H1N1 flu vaccine this week. Local clinics and doctor's offices will receive small shipments of the FluMist nasal spray vaccine as soon as Wednesday, according to a statement released Friday from the Los Angeles County Department of Public Health. "While the FluMist nasal spray vaccine may not be appropriate for everyone, we do encourage those who can receive this form of the vaccine to get it," said Jonathan E. Fielding, the county's director of public health.
September 24, 2009 | Thomas H. Maugh II
Injectable vaccines containing inactivated viruses prevent about 50% more seasonal flu in healthy adults than the intranasal vaccine containing a weakened virus, according to a report published online Wednesday in the New England Journal of Medicine. "We have two effective vaccines," said Dr. Arnold S. Monto of the University of Michigan, who led the study. "In children, I would prefer FluMist [intranasal vaccine] and in adults, injected, based on the data we have. However, an adult who does not want a shot should take FluMist."
November 30, 2008 | times wire services
Despite recommendations from the government and doctors, only 52% of U.S. adults said they planned on getting vaccinated against the flu this year, according to a Consumer Reports survey. Among the excuses: 27% said they disliked shots -- even though a nasal spray is available -- and 5% said they would rather get sick than go to work. Nearly half of those who said they wouldn't get the shot said they didn't get sick, while 67% said it was better to build up a natural immunity to influenza.
February 19, 2007 | Dennis O'Brien, Baltimore Sun
A nasal spray appears to be more effective than flu shots in protecting children younger than 5, according to a major study published last week. "It's good news. We need it, we need a new flu vaccine for children," said Dr. Neal A. Halsey, director of the Institute for Vaccine Safety at Johns Hopkins' Bloomberg School of Public Health. He was not involved in the study.
March 15, 2004 | Jane E. Allen, Times Staff Writer
The safety of zinc gluconate nasal sprays taken to ease symptoms and shorten the duration of the common cold is under review following reports that people lost their sense of smell after using the products. The reports involve people who used Zicam Cold Remedy nasal gel or Cold-Eeze Cold Remedy nasal spray, both of which are sold over the counter.
October 9, 1995 | SHARI ROAN
What's new in the treatment of osteoporosis? Fosamax. Approved last week, Fosamax is the first new drug for osteoporosis in 20 years. The drug, chemically known as alendronate, helps to increase bone density. Calcitonin nasal spray. The hormone calcitonin, now available as an injectable medication, may soon be approved as a nasal spray. The medication helps slow the rate of bone loss. Sodium fluoride. An experimental regimen using a slow-release form of the chemical has shown promise in increasing bone strength and reducing the risk of fracture.
Los Angeles Times Articles